Screener
Eli Lilly LLY EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Eli Lilly in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Eli Lilly’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 2:40 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000059478-26-000081
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Income taxes | 2,152 | 1,116 | 3,606 | 1,813 |
| Net income | $7,095 | $5,661 | $14,491 | $8,420 |
| Earnings per share: | ||||
| Basic | $7.95 | $6.30 | $16.22 | $9.37 |
| Diluted | $7.94 | $6.29 | $16.19 | $9.35 |
| Shares used in calculation of earnings per share: | ||||
| Basic | 892.4 | 897.9 | 893.5 | 898.3 |
| Diluted | 893.7 | 899.8 | 894.8 | 900.2 |
Item 1. Financial Statements
FAQ
- What is Eli Lilly's EPS (diluted)?
- Eli Lilly (LLY) reported EPS (diluted) of $7.94 in Q2 2026.
- How has Eli Lilly's EPS (diluted) changed year-over-year?
- Eli Lilly's EPS (diluted) increased by 26.2% year-over-year, from $6.29 to $7.94.
- What is the long-term trend for Eli Lilly's EPS (diluted)?
- Over 4 years (2021 to 2025), Eli Lilly's EPS (diluted) has grown at a 39.1% compound annual growth rate (CAGR), from $6.13 to $22.95.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Eli Lilly's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude